About my research
Antimicrobial stewardship; Clostridioides difficile; Acinetobacter; bacterial toxins; human serum albumin and infections; ICU infections; MDR infections; infection in the critically ill; fosfomycin; antibiotic synergism; vancomycin-resistant enterococci; oritavancin.
All Stories
- ArticleAntibiotic resistances of Clostridium perfingens isolated from bloodstream infections
- ArticleZebrafish (Danio rerio) as a Model System to Investigate the Role of the Innate Immune Response in Human Infectious Diseases
- ArticleBRAF-Mutated Melanoma Cell Lines Develop Distinct Molecular Signatures After Prolonged Exposure to AZ628 or Dabrafenib: Potential Benefits of the Antiretroviral Treatments Cabotegravir or Doravirine on BRAF-Inhibitor-Resistant Cells
- ArticleBioFire® Joint Infection Panel for Samples Other Than Synovial Fluid
- ArticleUsing a Fosfomycin and Oritavancin Combination in Vascular Grafts to Prevent Infection
- ArticleSeptic patients with elevated serum IRAK-M and galectin-1 had low survival rates.
- ArticleRisk factors for mortality in enterococcal BSI
- ArticlePredicting sepsis at emergency department triage
- ArticleTemocillin + fosfomycin vs KPC-producing Klebsiella pneumoniae
- ArticleHuman serum albumin binds SARS-CoV-2 spike protein competing with ACE2
- ArticleHuman Campylobacter infections in Italy
- ArticleSynergistic Activity of Temocillin and Fosfomycin Combination against KPC-Producing <em>Klebsiella pneumoniae </em>Clinical Isolates
- ArticleComprehensive review on Clostridioides difficile infection in humans
- ArticleThe antiretroviral cabotegravir inhibits melanoma cell growth and invasion
- ArticleAntibiotics Usage in Special Clinical Situations
- Articleβ-lactam/β-lactamase inhibitors and cefiderocol: what clinicians need to know
- ArticleReactivation of Herpes Simplex Virus Type 1 (HSV-1) Detected on Bronchoalveolar Lavage Fluid (BALF) Samples in Critically Ill COVID-19 Patients Undergoing Invasive Mechanical Ventilation: Preliminary Results from Two Italian Centers
- ArticleMycoplasma hominis and Ureaplasma antimicrobial resistances
- ArticleEnterococcal meningitis associated with Strongyloides infection
- ArticleDracunculiasis' distribution
- ArticleIntravenous fosfomycin for Pseudomonas infections
- ArticleNew Antimicrobials for Gram-Positive Sustained Infections: A Comprehensive Guide for Clinicians
- ArticleEnterobius vermicularis spleen abscess
- ArticleOritavancin + fosfomycin for VRE BSI
- ArticleRalstonia mannitololytica outbreak
- ArticleEndemic Systemic Mycoses in Italy: A Systematic Review of Literature and a Practical Update
- ArticleNew polyimidazole ligands against MBL
- ArticleCeftriaxone for methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia: a matter of dosages?
- ArticleCandida lipolytica Bloodstream Infection in an Adult Patient with COVID-19 and Alcohol Use Disorder: A Unique Case and a Systematic Review of the Literature
- ArticleDiverticular Disease and Rifaximin
- ArticleInfective portal vein thrombosis (pylephlebitis). A clinical review
- ArticleThe in vitro inhibitory activity of polypyridine ligands towards subclass B1 metallo-β-lactamases
- ArticleAcinetobacter resistance to sulbactam/durlobactam
- ArticleProlonged higher dose methylprednisoloneversusconventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS)
- ArticleOritavancin + fosfomycin against VRE
- ArticleSulbactam/durlobactam activity against Acinetobacter in Italy
- ArticleMoxifloxacin vs anaerobes
- ArticleHSV reactivation in COVID-19
- ArticleSteroids in COVID-19 outpatients
- ArticleCutaneous nocardiosis
- ArticleBloodstream infections by anaerobes and antibiotic resistances
- ArticleEditorial for the Special Issue: “Antibiotic Use in Clinical Infection: How to Reinvent Old Molecules and How to Squeeze out New Ones”
- ArticleAdiponectin and leptin in COVID-19
- ArticleLow albumin and COVID-19 mortality
- ArticleMicrobiological, clinical, and PK/PD features of the new BL/BLI and cefiderocol
- ArticleTemocillin: a carbapenem-sparing option
- ArticleCorrection: Morroni et al. Antimicrobial Activity of Aztreonam in Combination with Old and New β-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections. Antib...
- ArticleIt is time to define an organizational model for the prevention and management of infections along the surgical pathway: a worldwide cross-sectional survey
- ArticleLow vitamin D and low albumin are associated with threefold COVID-19 mortality.
- ArticleHSV-1 in BAL of COVID-19 patients
- ArticlePCSK9 in Infectious Diseases
- ArticleCytosorb removal of antibacterials and antifungals
- ArticleAspirin and infection
- ArticleWSES/GAIS/WSIS/SIS-E/AAST global clinical pathways for patients with skin and soft tissue infections
- ArticleNew bronchiectasis in COVID-19 may suggest aspergillosis
- ArticleAntibiotics in Liver Cirrhosis: Choosing the Right Treatment
- ArticleLarge neck = higher COVID-19 mortality
- ArticleZidovudine/azidothymidine (AZT) unexpressed clinical potential against multidrug-resistant Gram negatives
- ArticleHCV and nervous system disorders
- ArticleAztreonam + (clavulanate, sulbactam, tazobactam, vaborbactam, avibactam, zidebactam) vs ESBL and MBL
- ArticleWSES/GAIS/SIS-E/WSIS/AAST global clinical pathways for patients with intra-abdominal infections
- ArticleAztreonam against MBL-producing bacteria
- ArticleProfiling of Oral Microbiota and Cytokines in COVID-19 Patients
- ArticleFecal and serum calprotectin in COVID-19
- ArticlePica (Allotriophagy): An Underestimated Risk Factor for Severe Leptospirosis (Weil’s Diseases)? Report of a Leptospira Septic Shock Successfully Managed with ECMO
- ArticleZidovudine + fosfomycin vs MDR Enterobacterales
- ArticleCeftazidime/avibactam resistance
- ArticlePsoas haematoma in COVID-19 (case series)
- ArticleImpaired Right Ventricular Longitudinal Strain Without Pulmonary Hypertension in Patients Who Have Recovered From COVID-19
- ArticleHow to treat vanB VRE
- ArticleEnterococcus BSI in Italy. Incidence and antibiotic resistance
- ArticleProspective Study on Incidence, Risk Factors and Outcome of Recurrent Clostridioides difficile Infections
- ArticleIntravenous fosfomycin dosing regimens
- ArticleIncidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study
- ArticleBCG infection (BCGitis)
- ArticlePolypyridine ligands as potential metallo-β-lactamase inhibitors
- ArticleProfiling of oral microbiota and cytokines in COVID-19 patients
- ArticleAlbumin binds streptolysin O (produced by S. pyogenes)
- ArticleExtra-intestinal effects of Clostridioides difficile in zebrafish
- ArticleBacterial colonization of explanted non-endocarditis cardiac valves: evidence and characterization of the valvular microbiome
- ArticleGut microbes interaction with the enteric nervous system
- ArticleSpontaneous rectal perforation in COVID-19
- ArticleFosfomycin + chloramphenicol vs VRE
- ArticleCOVID-19-Induced Thrombosis in Patients without Gastrointestinal Symptoms and Elevated Fecal Calprotectin: Hypothesis Regarding Mechanism of Intestinal Damage Associated with COVID-19
- ArticlePainful thoracic swelling in a refugee teenager
- ArticleThe Model for Early COvid-19 Recognition (MECOR) Score: A Proof-of-Concept for a Simple and Low-Cost Tool to Recognize a Possible Viral Etiology in Community-Acquired Pneumonia Patients during COVID-19 Outbreak
- ArticleWith which antibiotics does fosfomycin synergize?
- ArticleInterferon: The invisible link in the physiopathology of COVID‐19 and BCGitis?
- ArticleAntimicrobial stewardship examples
- ArticleBezlotoxumab for Preventing Recurrent Clostridioides difficile Infection: A Narrative Review from Pathophysiology to Clinical Studies
- ArticleCOVID-19 patients with "large neck" are more frequently intubated
- ArticleZinc chelators restore meropenem activity against MBL-producing bacteria
- ArticleCommunity pharmacists' exposure to COVID-19
- ArticleUse of colistin in adult patients: A cross-sectional study
- ArticleDengue vaccines
- ArticleMeasles pathophysiology
- ArticleA proposal for a comprehensive approach to infections across the surgical pathway
- ArticleClinical Features and Mortality of Nosocomial Candidemia in Very Old Patients: A Multicentre Italian Study
- ArticleCSF pentraxin 3 in meningitis/encephalitis
- ArticleMycobacterium chimaera infections
- ArticleTuberculosis screening in outpatient healthcare workers: lessons from a high-income, low TB burden country
- ArticleManagement of aortic prosthesis infections.
- ArticleTick-borne encephalitis (TBE)
- Article2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients
- ArticleSeptic Cardiomyopathy and Bacterial Exotoxins
- ArticleColistin-associated acute kidney injury is higher in patients with low albumin
- ArticleHistory of schistosomiasis
- ArticleHuman albumin neutralizes Clostridioides difficile toxins
- ArticleRole of fecal microbiota transplantation in inflammatory bowel disease
- ArticleEmergence of quinolone-resistant Shigella flexneri in Italy (March 2017)
- ArticleClinical management of non-faecium non-faecalis VRE
- ArticleEvaluation and Management of Lower-Extremity Ulcers
- ArticleNosocomial Infections During Extracorporeal Membrane Oxygenation
- ArticleJaneway lesions
- ArticleInfections during extracorporeal membrane oxygenation: epidemiology, risk factors, pathogenesis and prevention
- ArticleFever and Vision Loss in an Immunocompetent 20-Year-Old Male
- ArticleQuestion: Fever and Vision Loss in an Immunocompetent 20-Year-Old Male
- ArticleExtraintestinal effects of Clostridioides difficile toxins
- ArticleHertoghe sign: a hallmark of lepromatous leprosy
- ArticleRe: The challenge of Clostridium difficile infection: Overview of clinical manifestations, diagnostic tools and therapeutic options
- ArticleLock therapy with tigecycline for Klebsiella pneumoniae KPC
- ArticleAlbumin prevents death in enterocytes exposed to Clostridioides difficile toxin B
- ArticleWSES guidelines for management of Clostridium difficile infection in surgical patients
- ArticleThe impact of Clostridium difficile infection on resource use and costs in hospitals in Spain and Italy: a matched cohort study
- ArticleIs tigecycline a suitable option for Clostridium difficile infection? Evidence from the literature
- ArticlePainful Lesions In An HIV-1 Seropositive African Woman.
- ArticleClostridium difficile infection among hospitalized HIV-infected individuals: epidemiology and risk factors: results from a case-control study (2002-2013)
- ArticleUterus-God in the Michealngelo's painting "Creation of Adam"
- ArticleFecal microbiota transplantation (FMT) for Clostridium difficile infection: Focus on immunocompromised patients
- ArticleCould chloramphenicol be used against ESKAPE pathogens? A review ofin vitrodata in the literature from the 21st century
- ArticleAcinetobacter Infections
- ArticleManagement of antibiotic resistance in the intensive care unit setting from an international perspective
- ArticleHoloinspiratory Wheezing in a 46-Year-Old HIV-Seropositive Man
- ArticleFecal microbiota transplantation: the state of the art
- ArticleAre There Reasons To Prefer Tetracyclines to Macrolides in Older Patients with Community-Acquired Pneumonia?
- ArticleCarbapenemase-producingKlebsiella pneumoniae-related mortality among solid organ-transplanted patients: do we know enough?
- ArticleTelavancin and daptomycin activity against meticillin-resistant Staphylococcus aureus strains after vancomycin-resistance selection in vitro
- ArticleMultiple Bilateral Pulmonary “Fungus Balls” in an Immunocompetent Patient Unsuitable for Surgical Treatment: Efficacy of Azoles Treatment
- ArticleClostridium difficile infection in Italian urban hospitals: data from 2006 through 2011
- ArticleP231: Risk factors for Acinetobacter baumannii colonization and infection among patients admitted to intensive care units
- ArticleClostridium difficile 027 infection in Central Italy
- ArticleWhen an Infection Prompts Removal of an Unnecessary Device
- ArticleKaposi’s sarcoma symmetric mucosal lesions
- ArticleCases of cryptosporidiosis co-infections in AIDS patients: a correlation between clinical presentation and GP60 subgenotype lineages from aged formalin-fixed stool samples
- ArticleVertebral Lesions from AIDS-Related Kaposi's Sarcoma
- ArticleSalmonella enterica ssp. arizonae infection in a 43-year-old Italian man with hypoglobulinemia: a case report and review of the literature
- ArticleSelenium deficiency and HIV infection
- ArticleManagement of antibiotic resistance in the intensive care unit setting
- ArticleThe novel influenza A (H1N1) virus pandemic: An update